论文部分内容阅读
自1997年以来,我们采用乳果糖口服及保留灌肠辅助治疗肝性脑病42例,取得了满意的疗效,报告如下。 1 对象与方法 1.1 对象肝病并发肝性脑病82例,其中急性暴发性肝炎5例,亚急性重型肝炎18例,慢性重型肝炎16例,肝硬化失代偿32例,原发性肝癌11例。31例血氨>58.7μmol/L,45例在37～58.7 μmol/L之间,6例在正常范围(正常值10～37 μmol/L)。随机分为两组:观察组42例,男30例,女12例;年龄22～77岁;其中肝性脑病Ⅰ期2例,Ⅱ期23例,Ⅲ期15例,Ⅳ期2例,发病诱因为高蛋白
Since 1997, we used lactulose oral and retention enema adjuvant treatment of 42 cases of hepatic encephalopathy, and achieved satisfactory results, the report is as follows. 1 Subjects and methods 1.1 The object of liver disease complicated with hepatic encephalopathy in 82 cases, of which 5 cases of acute fulminant hepatitis, 18 cases of subacute severe hepatitis, 16 cases of chronic severe hepatitis, cirrhosis 32 cases of decompensation, 11 cases of primary liver cancer. 31 cases of blood ammonia> 58.7μmol / L, 45 cases of 37 ~ 58.7μmol / L, 6 cases in the normal range (normal 10 ~ 37μmol / L). Randomly divided into two groups: the observation group of 42 patients, 30 males and 12 females; aged 22 to 77 years; of which 2 cases of hepatic encephalopathy stage Ⅰ, 23 cases of stage Ⅱ, 15 cases of stage Ⅲ, 2 cases of stage Ⅳ, The incentive is high protein